|
 | |  | |  | |  | |  | |
|
Aristo launches Probi’s probiotics in IndiaProbi’s partner Institut Rosell has signed an agreement with the pharmaceutical company Aristo Pharmaceuticals Ltd. to launch a dietary supplement based on Probi’s probiotics Lp 299v on the Indian market. Launch is planned for the fall of 2007. With this agreement, Probi’s probiotics are being launched in the world’s three most populated countries. Aristo Pharmaceuticals Ltd. is a dynamic and rapidly growing pharmaceutical company that is aiming for a position among the top five pharmaceutical companies in India. “We are proud to expand the list of strategically important distributors with Aristo Pharmaceuticals”, says Per-Ola Forsberg, executive vice president of Probi. “High quality products, marketed by high quality distributors, will help to develop Probi´s share of the market substantially. With the new agreement, our probiotics will be launched in the world’s three most populated countries: India, China and the US.” Including the agreement with Aristo Pharmaceuticals, marketing of dietary supplements containing Probi’s probiotics is under way in fifteen countries. The majority of the agreements have been signed within the past twelve months. Considering the great interest shown by customers, prospects are good that the business area Dietary Supplements will, within a two-year period, reach the same sales level as shown by the business area Functional Food today. Source: www.probi.se
|
News from "Business News"
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|